Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Publication | Open Access

DOI Full Paper Access

Citations

References

2015

Year

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki, Gregory A. Masters, George Blumenschein, Steven E. Schild, Jeffrey A. Bogart, Chen Hu, Kenneth Forster, Anthony M. Magliocco,

The Lancet Oncology

Consolidation CarboplatinOncologyRadiation TherapyRtog 0617Stage IiiaCancer TreatmentMedicineRadiation OncologyLung Cancer